GILEAD SCIENCES INC
Insider CIK 882095 · ASMB 10% owner · RCUS 10% owner · ALVR 10% owner · XLO 10% owner · KYTX 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ASMB ASSEMBLY BIOSCIENCES, INC. | A Award | 2026-05-26 | 2026-05-27 | 471,698 | $26.50 | $12.50M | 4,977,089 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | P Buy deriv | 2026-02-13 | 2026-02-17 | 3,739,000 | $0.53 | $1.98M | 40,384,266 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | X Exercise deriv | 2025-11-26 | 2025-12-01 | 13,335,000 | $0.75 | $10.00M | 36,645,266 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | X Exercise deriv | 2025-11-26 | 2025-12-01 | 13,335,000 | — | $0 | 0 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | P Buy deriv | 2025-08-08 | 2025-10-03 | 1,147,960 | — | $0 | 1,147,960 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | P Buy deriv | 2025-08-08 | 2025-10-03 | 1,147,960 | — | $0 | 1,147,960 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | P Buy | 2025-08-08 | 2025-10-03 | 2,295,920 | — | $0 | 4,505,391 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | P Buy deriv | 2025-06-05 | 2025-06-06 | 13,335,000 | — | $0 | 13,335,000 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | P Buy deriv | 2025-06-05 | 2025-06-06 | 13,335,000 | — | $0 | 13,335,000 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | P Buy deriv | 2025-06-05 | 2025-06-06 | 13,335,000 | — | $0 | 23,310,266 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | P Buy deriv | 2025-06-05 | 2025-06-06 | 13,335,000 | — | $0 | 13,335,000 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | P Buy | 2025-02-18 | 2025-02-20 | 1,363,636 | $11.00 | $15.00M | 31,424,760 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | P Buy | 2024-12-19 | 2024-12-23 | 940,499 | $21.37 | $20.10M | 2,209,471 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | P Buy deriv | 2024-12-18 | 2024-12-19 | 6,092,816 | $1.04 | $6.34M | 9,975,266 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | P Buy | 2024-12-18 | 2024-12-19 | 1,759,978 | $1.04 | $1.83M | 9,105,451 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | P Buy deriv | 2024-06-17 | 2024-06-20 | 179,500 | — | $0 | 179,500 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | P Buy | 2024-06-17 | 2024-06-20 | 179,500 | — | $0 | 1,268,972 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | P Buy deriv | 2024-04-02 | 2024-04-03 | 3,882,450 | $0.76 | $2.95M | 3,882,450 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | P Buy | 2024-04-02 | 2024-04-03 | 485,250 | $0.76 | $368.8K | 7,345,473 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | C Conversion deriv | 2024-02-12 | 2024-02-13 | 7,746,139 | — | $0 | 0 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | C Conversion deriv | 2024-02-12 | 2024-02-13 | 6,890,744 | — | $0 | 0 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | P Buy | 2024-02-12 | 2024-02-13 | 910,000 | $22.00 | $20.02M | 4,126,119 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | C Conversion | 2024-02-12 | 2024-02-13 | 3,216,119 | — | $0 | 3,216,119 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | P Buy | 2024-01-29 | 2024-01-31 | 15,238,095 | $21.00 | $320.00M | 30,061,124 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | P Buy | 2023-06-28 | 2023-06-30 | 1,010,000 | $19.26 | $19.45M | 14,823,029 | SEC↗ |
| ALVR Allovir, Inc. | P Buy | 2023-06-27 | 2023-06-28 | 2,930,870 | $3.75 | $10.99M | 16,635,286 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | P Buy | 2021-01-31 | 2021-02-02 | 5,650,000 | $39.00 | $220.35M | 13,913,029 | SEC↗ |